GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 805 filers reported holding GLAXOSMITHKLINE PLC in Q3 2019. The put-call ratio across all filers is 0.81 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $273,000 | +4.2% | 6,269 | +5.6% | 0.03% | +28.6% |
| Q1 2022 | $262,000 | 0.0% | 5,934 | 0.0% | 0.02% | 0.0% |
| Q4 2021 | $262,000 | +27.8% | 5,934 | +17.9% | 0.02% | -27.6% |
| Q2 2020 | $205,000 | -6.0% | 5,032 | -12.7% | 0.03% | -29.3% |
| Q1 2020 | $218,000 | -28.5% | 5,766 | -10.0% | 0.04% | -14.6% |
| Q4 2019 | $305,000 | +11.3% | 6,404 | -0.1% | 0.05% | -4.0% |
| Q3 2019 | $274,000 | +22.3% | 6,412 | +14.7% | 0.05% | +11.1% |
| Q2 2019 | $224,000 | – | 5,590 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Black Creek Investment Management Inc. | 7,951,626 | $318,224,000 | 10.49% |
| Healthcare Value Capital, LLC | 120,000 | $4,802,000 | 9.01% |
| KAHN BROTHERS GROUP INC | 1,605,014 | $64,232,661,000 | 8.03% |
| Eversept Partners, LP | 693,685 | $28,091,890 | 7.87% |
| EQUITY INVESTMENT CORP | 2,673,764 | $107,004,000 | 3.74% |
| Sio Capital Management, LLC | 379,500 | $15,188,000 | 3.66% |
| Martin Capital Partners, LLC | 115,448 | $4,620,000 | 3.27% |
| Circle Road Advisors LP | 53,028 | $2,122,000 | 3.10% |
| Keystone Financial Planning, Inc. | 156,968 | $6,282,000 | 3.07% |
| CAMG Solamere Management, LLC | 160,294 | $6,415,000 | 2.94% |